Features

Latest Features

Novel Monoclonal Antibody Could Change the Management of Myelofibrosis

By

Kyle Habet, MD

Promising results from a preclinical experiment have the potential to modify how myelofibrosis is treated in the future.

Does AATD Cause Lung Cancer Among Never-Smokers?

By

Ryner Lai, MBBS

Studies demonstrate that alpha-1 antitrypsin deficiency does not predispose a never-smoker to lung cancer.

Molecular Mysteries Hidden in PNH

By

Kyle Habet, MD

The PIGA gene mutation alone does not explain the pathophysiology of PNH. The clonal expansion of PNH cells remains a mystery.

Nation’s First CureDuchenne Clinic Opens in Texas for Hispanic Patients With DMD

By

Larry Luxner

The nation’s first CureDuchenne Clinic has opened in a suburb of Dallas, Texas, to treat Hispanic patients with rare neuromuscular diseases.

US Clinics Build Data Hub for Historically Marginalized Sickle Cell Disease

By

Larry Luxner

The American Society of Hematology (ASH) is establishing a nationwide learning community to improve the care and quality of life of people with SCD.

Accelerating and Improving the Diagnosis of Wilson Disease

By

Tori Rodriguez, MA, LPC, AHC

Untreated Wilson disease can eventually result in death, but patients who receive adequate treatment can have a normal lifespan

Zinc Could Hold Key to Reversing IPF, Leading Pulmonologist Dr. Paul Noble Says

By

Larry Luxner

Prominent pulmonologist Paul W. Noble, MD, says zinc may be the key to treating and even reversing idiopathic pulmonary fibrosis.

Case Study Highlights COVID-19 Vaccine-Induced Prothrombotic ITP

By

Ryner Lai, MBBS

Researchers described the case study of a patient with vaccine-induced prothrombotic immune thrombocytopenia.

Immunosuppression as a Therapeutic Strategy in ITP Examined

By

Ryner Lai, MBBS

The incidence of many rare diseases is rising rapidly, especially in the Western world, and advancements in therapeutics have not quite caught up. In the United States, for example, billions of dollars are being spent annually for treating autoimmune disorders and conducting trials to find future solutions.  Immune thrombocytopenia (ITP) is one such disease; it…

Understanding the Relationship Between AAV and Cardiovascular Disease

By

Ryner Lai, MBBS

Studies indicate that patients with ANCA-associated vasculitis have a heightened risk of developing cardiovascular disease.